{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:59:33Z","timestamp":1790762373821,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00262-022-03284-4","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T14:04:00Z","timestamp":1662041040000},"page":"707-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression"],"prefix":"10.1007","volume":"72","author":[{"given":"Tehila","family":"Azoulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Slouzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Karmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Filatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Hayun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishai","family":"Ofran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Sarig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-1466","authenticated-orcid":false,"given":"Shimrit","family":"Ringelstein-Harlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"9","key":"3284_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nri2154","volume":"7","author":"ND Huntington","year":"2007","unstructured":"Huntington ND, Vosshenrich CA, Di Santo JP (2007) Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 7(9):703\u2013714. https:\/\/doi.org\/10.1038\/nri2154","journal-title":"Nat Rev Immunol"},{"key":"3284_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225\u2013274. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115526","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"3284_CR3","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1182\/blood.v97.10.3146","volume":"97","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T, Carson WE, Caligiuri MA (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97(10):3146\u20133151. https:\/\/doi.org\/10.1182\/blood.v97.10.3146","journal-title":"Blood"},{"issue":"5","key":"3284_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/sj.leu.2403704","volume":"19","author":"O Penack","year":"2005","unstructured":"Penack O, Gentilini C, Fischer L, Asemissen AM, Scheibenbogen C, Thiel E, Uharek L (2005) CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets. Leukemia 19(5):835\u2013840. https:\/\/doi.org\/10.1038\/sj.leu.2403704","journal-title":"Leukemia"},{"issue":"1","key":"3284_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4049\/jimmunol.179.1.89","volume":"179","author":"A Chan","year":"2007","unstructured":"Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, Buckley CD, McMichael A, Enver T, Bowness P (2007) CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 179(1):89\u201394. https:\/\/doi.org\/10.4049\/jimmunol.179.1.89","journal-title":"J Immunol"},{"issue":"4","key":"3284_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3324\/haematol.2014.116053","volume":"100","author":"H Stabile","year":"2015","unstructured":"Stabile H, Nisti P, Morrone S, Pagliara D, Bertaina A, Locatelli F, Santoni A, Gismondi A (2015) Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients. Haematologica 100(4):489\u2013498. https:\/\/doi.org\/10.3324\/haematol.2014.116053","journal-title":"Haematologica"},{"issue":"45","key":"3284_CR7","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1038\/onc.2008.267","volume":"27","author":"I Waldhauer","year":"2008","unstructured":"Waldhauer I, Steinle A (2008) NK cells and cancer immunosurveillance. Oncogene 27(45):5932\u20135943. https:\/\/doi.org\/10.1038\/onc.2008.267","journal-title":"Oncogene"},{"issue":"9","key":"3284_CR8","first-page":"1909","volume":"30","author":"R Harning","year":"1989","unstructured":"Harning R, Koo GC, Szalay J (1989) Regulation of the metastasis of murine ocular melanoma by natural killer cells. Invest Ophthalmol Vis Sci 30(9):1909\u20131915","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3284_CR9","first-page":"3522","volume":"44","author":"JM Kozlowski","year":"1984","unstructured":"Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44(8):3522\u20133529","journal-title":"Cancer Res"},{"issue":"4","key":"3284_CR10","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/intimm\/dxn028","volume":"20","author":"MJ Smyth","year":"2008","unstructured":"Smyth MJ (2008) NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int Immunol 20(4):631. https:\/\/doi.org\/10.1093\/intimm\/dxn028","journal-title":"Int Immunol"},{"issue":"9244","key":"3284_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","volume":"356","author":"K Imai","year":"2000","unstructured":"Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356(9244):1795\u20131799. https:\/\/doi.org\/10.1016\/S0140-6736(00)03231-1","journal-title":"Lancet"},{"issue":"1","key":"3284_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K (2007) Cancer immunoediting from immune surveillance to immune escape. Immunology 121(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02587.x","journal-title":"Immunology"},{"issue":"3","key":"3284_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/0016-5085(86)90626-8","volume":"91","author":"JF Markowitz","year":"1986","unstructured":"Markowitz JF, Aiges HW, Cunningham-Rundles S, Kahn E, Teichberg S, Fisher SE, Daum F (1986) Cancer family syndrome: marker studies. Gastroenterology 91(3):581\u2013589. https:\/\/doi.org\/10.1016\/0016-5085(86)90626-8","journal-title":"Gastroenterology"},{"issue":"3","key":"3284_CR14","first-page":"525","volume":"60","author":"RP Warren","year":"1985","unstructured":"Warren RP, Stembridge AM, Gardner EJ (1985) Deficient immune function of peripheral blood mononuclear cells from patients with Gardner syndrome. Clin Exp Immunol 60(3):525\u2013531","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"3284_CR15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1","volume":"29","author":"S Sivori","year":"1999","unstructured":"Sivori S, Pende D, Bottino C, Marcenaro E, Pessino A, Biassoni R, Moretta L, Moretta A (1999) NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur J Immunol 29(5):1656\u20131666","journal-title":"Eur J Immunol"},{"issue":"10","key":"3284_CR16","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1182\/blood.v99.10.3661","volume":"99","author":"RT Costello","year":"2002","unstructured":"Costello RT, Sivori S, Marcenaro E, Lafage-Pochitaloff M, Mozziconacci MJ, Reviron D, Gastaut JA, Pende D, Olive D, Moretta A (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99(10):3661\u20133667. https:\/\/doi.org\/10.1182\/blood.v99.10.3661","journal-title":"Blood"},{"issue":"5","key":"3284_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3324\/haematol.2013.087536","volume":"99","author":"K Stringaris","year":"2014","unstructured":"Stringaris K, Sekine T, Khoder A, Alsuliman A, Razzaghi B, Sargeant R, Pavlu J, Brisley G, de Lavallade H, Sarvaria A, Marin D, Mielke S, Apperley JF, Shpall EJ, Barrett AJ, Rezvani K (2014) Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica 99(5):836\u2013847. https:\/\/doi.org\/10.3324\/haematol.2013.087536","journal-title":"Haematologica"},{"key":"3284_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1756-9966-30-37","volume":"30","author":"B Weiss-Steider","year":"2011","unstructured":"Weiss-Steider B, Soto-Cruz I, Martinez-Campos CA, Mendoza-Rincon JF (2011) Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells. J Exp Clin Cancer Res 30:37. https:\/\/doi.org\/10.1186\/1756-9966-30-37","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"3284_CR19","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1182\/blood-2006-07-035519","volume":"109","author":"PK Epling-Burnette","year":"2007","unstructured":"Epling-Burnette PK, Bai F, Painter JS, Rollison DE, Salih HR, Krusch M, Zou J, Ku E, Zhong B, Boulware D, Moscinski L, Wei S, Djeu JY, List AF (2007) Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood 109(11):4816\u20134824. https:\/\/doi.org\/10.1182\/blood-2006-07-035519","journal-title":"Blood"},{"issue":"1","key":"3284_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/icb.2011.15","volume":"90","author":"B Sanchez-Correa","year":"2012","unstructured":"Sanchez-Correa B, Gayoso I, Bergua JM, Casado JG, Morgado S, Solana R, Tarazona R (2012) Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients. Immunol Cell Biol 90(1):109\u2013115. https:\/\/doi.org\/10.1038\/icb.2011.15","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"3284_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/imm.12082","volume":"139","author":"RT Costello","year":"2013","unstructured":"Costello RT, Boehrer A, Sanchez C, Mercier D, Baier C, Le Treut T, Sebahoun G (2013) Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy. Immunology 139(3):338\u2013341. https:\/\/doi.org\/10.1111\/imm.12082","journal-title":"Immunology"},{"issue":"5","key":"3284_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/eji.201242733","volume":"43","author":"A Danielou-Lazareth","year":"2013","unstructured":"Danielou-Lazareth A, Henry G, Geromin D, Khaznadar Z, Briere J, Tamouza R, Cayuela JM, Thieblemont C, Toubert A, Dulphy N (2013) At diagnosis, diffuse large B-cell lymphoma patients show impaired rituximab-mediated NK-cell cytotoxicity. Eur J Immunol 43(5):1383\u20131388. https:\/\/doi.org\/10.1002\/eji.201242733","journal-title":"Eur J Immunol"},{"issue":"7","key":"3284_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/annonc\/mdm110","volume":"18","author":"A Plonquet","year":"2007","unstructured":"Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, Feugier P, Rabian C, Casasnovas O, Labalette M, Kuhlein E, Farcet JP, Emile JF, Gisselbrecht C, Delfau-Larue MH, Groupe d\u2019etude des lymphomes de la (2007) Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2\u20133 diffuse large B-cell lymphoma. Ann Oncol 18(7):1209\u20131215. https:\/\/doi.org\/10.1093\/annonc\/mdm110","journal-title":"Ann Oncol"},{"issue":"8","key":"3284_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.67","volume":"6","author":"L He","year":"2016","unstructured":"He L, Zhu HY, Qin SC, Li Y, Miao Y, Liang JH, Xia Y, Wang Y, Wu YJ, Wang L, Fan L, Li JY, Xu W (2016) Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma. Blood Cancer J 6(8):e457. https:\/\/doi.org\/10.1038\/bcj.2016.67","journal-title":"Blood Cancer J"},{"issue":"15","key":"3284_CR25","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1158\/1078-0432.CCR-18-3270","volume":"25","author":"M Klanova","year":"2019","unstructured":"Klanova M, Oestergaard MZ, Trneny M, Hiddemann W, Marcus R, Sehn LH, Vitolo U, Bazeos A, Goede V, Zeuner H, Knapp A, Sahin D, Spielewoy N, Bolen CR, Cardona A, Klein C, Venstrom JM, Nielsen T, Fingerle-Rowson G (2019) Prognostic impact of natural killer cell count in follicular lymphoma and diffuse large B-cell lymphoma patients treated with immunochemotherapy. Clin Cancer Res 25(15):4634\u20134643. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3270","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3284_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ijc.2910230202","volume":"23","author":"LC Andersson","year":"1979","unstructured":"Andersson LC, Nilsson K, Gahmberg CG (1979) K562\u2013a human erythroleukemic cell line. Int J Cancer 23(2):143\u2013147. https:\/\/doi.org\/10.1002\/ijc.2910230202","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"3284_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","volume":"294","author":"G Alter","year":"2004","unstructured":"Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294(1\u20132):15\u201322. https:\/\/doi.org\/10.1016\/j.jim.2004.08.008","journal-title":"J Immunol Methods"},{"issue":"23","key":"3284_CR28","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1182\/blood-2012-08-453738","volume":"121","author":"K Krzewski","year":"2013","unstructured":"Krzewski K, Gil-Krzewska A, Nguyen V, Peruzzi G, Coligan JE (2013) LAMP1\/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood 121(23):4672\u20134683. https:\/\/doi.org\/10.1182\/blood-2012-08-453738","journal-title":"Blood"},{"issue":"15","key":"3284_CR29","doi-asserted-by":"publisher","first-page":"13835","DOI":"10.18632\/oncotarget.3453","volume":"6","author":"I Levi","year":"2015","unstructured":"Levi I, Amsalem H, Nissan A, Darash-Yahana M, Peretz T, Mandelboim O, Rachmilewitz J (2015) Characterization of tumor infiltrating natural killer cell subset. Oncotarget 6(15):13835\u201313843. https:\/\/doi.org\/10.18632\/oncotarget.3453","journal-title":"Oncotarget"},{"issue":"1","key":"3284_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1182\/blood-2005-11-4535","volume":"108","author":"JO Richards","year":"2006","unstructured":"Richards JO, Chang X, Blaser BW, Caligiuri MA, Zheng P, Liu Y (2006) Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood 108(1):246\u2013252. https:\/\/doi.org\/10.1182\/blood-2005-11-4535","journal-title":"Blood"},{"issue":"6","key":"3284_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood.V88.6.2279.bloodjournal8862279","volume":"88","author":"BA Pierson","year":"1996","unstructured":"Pierson BA, Miller JS (1996) CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. Blood 88(6):2279\u20132287","journal-title":"Blood"},{"issue":"11","key":"3284_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078049","volume":"8","author":"KC Koo","year":"2013","unstructured":"Koo KC, Shim DH, Yang CM, Lee SB, Kim SM, Shin TY, Kim KH, Yoon HG, Rha KH, Lee JM, Hong SJ (2013) Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer. PLoS ONE 8(11):e78049. https:\/\/doi.org\/10.1371\/journal.pone.0078049","journal-title":"PLoS ONE"},{"issue":"8","key":"3284_CR33","first-page":"3053","volume":"29","author":"S Wulff","year":"2009","unstructured":"Wulff S, Pries R, Borngen K, Trenkle T, Wollenberg B (2009) Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res 29(8):3053\u20133057","journal-title":"Anticancer Res"},{"issue":"1","key":"3284_CR34","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41598-019-40933-8","volume":"9","author":"K de Jonge","year":"2019","unstructured":"de Jonge K, Ebering A, Nassiri S, Maby-El Hajjami H, Ouertatani-Sakouhi H, Baumgaertner P, Speiser DE (2019) Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients. Sci Rep 9(1):4487. https:\/\/doi.org\/10.1038\/s41598-019-40933-8","journal-title":"Sci Rep"},{"issue":"3","key":"3284_CR35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clim.2008.08.012","volume":"129","author":"L Cai","year":"2008","unstructured":"Cai L, Zhang Z, Zhou L, Wang H, Fu J, Zhang S, Shi M, Zhang H, Yang Y, Wu H, Tien P, Wang FS (2008) Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin Immunol 129(3):428\u2013437. https:\/\/doi.org\/10.1016\/j.clim.2008.08.012","journal-title":"Clin Immunol"},{"issue":"4","key":"3284_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trneny M, Sharman JP, Herbaux C, Burke JM, Matasar M, Rai S, Izutsu K, Mehta-Shah N, Oberic L, Chauchet A, Jurczak W, Song Y, Greil R, Mykhalska L, Bergua-Burgues JM, Cheung MC, Pinto A, Shin HJ, Hapgood G, Munhoz E, Abrisqueta P, Gau JP, Hirata J, Jiang Y, Yan M, Lee C, Flowers CR, Salles G (2022) Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med 386(4):351\u2013363. https:\/\/doi.org\/10.1056\/NEJMoa2115304","journal-title":"N Engl J Med"},{"issue":"6","key":"3284_CR37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2010.08.031","volume":"142","author":"MT Orr","year":"2010","unstructured":"Orr MT, Lanier LL (2010) Natural killer cell education and tolerance. Cell 142(6):847\u2013856. https:\/\/doi.org\/10.1016\/j.cell.2010.08.031","journal-title":"Cell"},{"issue":"4","key":"3284_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","volume":"30","author":"P Brodin","year":"2009","unstructured":"Brodin P, Karre K, Hoglund P (2009) NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30(4):143\u2013149. https:\/\/doi.org\/10.1016\/j.it.2009.01.006","journal-title":"Trends Immunol"},{"issue":"1","key":"3284_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2567.2011.03415.x","volume":"133","author":"SY Al Omar","year":"2011","unstructured":"Al Omar SY, Marshall E, Middleton D, Christmas SE (2011) Increased killer immunoglobulin-like receptor expression and functional defects in natural killer cells in lung cancer. Immunology 133(1):94\u2013104. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03415.x","journal-title":"Immunology"},{"issue":"5","key":"3284_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.imbio.2019.06.002","volume":"224","author":"S Barani","year":"2019","unstructured":"Barani S, Hosseini SV, Ghaderi A (2019) Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis. Immunobiology 224(5):681\u2013686. https:\/\/doi.org\/10.1016\/j.imbio.2019.06.002","journal-title":"Immunobiology"},{"issue":"11 Pt 1","key":"3284_CR41","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1158\/1055-9965.EPI-05-0229","volume":"14","author":"M Butsch Kovacic","year":"2005","unstructured":"Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen CJ, Cheng YJ, Chen JY, Apple R, Hildesheim A, Carrington M (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2673\u20132677. https:\/\/doi.org\/10.1158\/1055-9965.EPI-05-0229","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"3284_CR42","doi-asserted-by":"publisher","first-page":"11343","DOI":"10.1038\/s41598-021-90596-7","volume":"11","author":"BM Muriuki","year":"2021","unstructured":"Muriuki BM, Forconi CS, Oluoch PO, Bailey JA, Ghansah A, Moormann AM, Ong\u2019echa JM (2021) Association of killer cell immunoglobulin-like receptors with endemic burkitt lymphoma in Kenyan children. Sci Rep 11(1):11343. https:\/\/doi.org\/10.1038\/s41598-021-90596-7","journal-title":"Sci Rep"},{"issue":"5","key":"3284_CR43","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI123955","volume":"129","author":"T Kamiya","year":"2019","unstructured":"Kamiya T, Seow SV, Wong D, Robinson M, Campana D (2019) Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest 129(5):2094\u20132106. https:\/\/doi.org\/10.1172\/JCI123955","journal-title":"J Clin Invest"},{"issue":"8","key":"3284_CR44","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-011-1050-2","volume":"60","author":"B Sanchez-Correa","year":"2011","unstructured":"Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R (2011) Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother 60(8):1195\u20131205. https:\/\/doi.org\/10.1007\/s00262-011-1050-2","journal-title":"Cancer Immunol Immunother"},{"issue":"6908","key":"3284_CR45","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nature01112","volume":"419","author":"V Groh","year":"2002","unstructured":"Groh V, Wu J, Yee C, Spies T (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419(6908):734\u2013738. https:\/\/doi.org\/10.1038\/nature01112","journal-title":"Nature"},{"issue":"9","key":"3284_CR46","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, Viens P, Birnbaum D, Bertucci F, Moretta A, Olive D (2011) Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 121(9):3609\u20133622. https:\/\/doi.org\/10.1172\/JCI45816","journal-title":"J Clin Invest"},{"key":"3284_CR47","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/1471-2407-14-738","volume":"14","author":"YP Peng","year":"2014","unstructured":"Peng YP, Zhang JJ, Liang WB, Tu M, Lu ZP, Wei JS, Jiang KR, Gao WT, Wu JL, Xu ZK, Miao Y, Zhu Y (2014) Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction. BMC Cancer 14:738. https:\/\/doi.org\/10.1186\/1471-2407-14-738","journal-title":"BMC Cancer"},{"issue":"5","key":"3284_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","volume":"2","author":"IP da Silva","year":"2014","unstructured":"da Silva IP, Gallois A, Jimenez-Baranda S, Khan S, Anderson AC, Kuchroo VK, Osman I, Bhardwaj N (2014) Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunol Res 2(5):410\u2013422. https:\/\/doi.org\/10.1158\/2326-6066.CIR-13-0171","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"3284_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1177\/030089160108700509","volume":"87","author":"V Jovic","year":"2001","unstructured":"Jovic V, Konjevic G, Radulovic S, Jelic S, Spuzic I (2001) Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma. Tumori 87(5):324\u2013329","journal-title":"Tumori"},{"issue":"26","key":"3284_CR50","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1182\/blood.2020005602","volume":"136","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Lam PY, Jiang H, Bednarska K, Gloury R, Murigneux V, Tay J, Jacquelot N, Li R, Tuong ZK, Leggatt GR, Gandhi MK, Hill MM, Belz GT, Ngo S, Kallies A, Mattarollo SR (2020) Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood 136(26):3004\u20133017. https:\/\/doi.org\/10.1182\/blood.2020005602","journal-title":"Blood"},{"issue":"3","key":"3284_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/a:1010602822483","volume":"66","author":"G Konjevic","year":"2001","unstructured":"Konjevic G, Jurisic V, Spuzic I (2001) Association of NK cell dysfunction with changes in LDH characteristics of peripheral blood lymphocytes (PBL) in breast cancer patients. Breast Cancer Res Treat 66(3):255\u2013263. https:\/\/doi.org\/10.1023\/a:1010602822483","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3284_CR52","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12032-007-0007-y","volume":"24","author":"V Jurisic","year":"2007","unstructured":"Jurisic V, Srdic T, Konjevic G, Markovic O, Colovic M (2007) Clinical stage-depending decrease of NK cell activity in multiple myeloma patients. Med Oncol 24(3):312\u2013317. https:\/\/doi.org\/10.1007\/s12032-007-0007-y","journal-title":"Med Oncol"},{"key":"3284_CR53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2021.09.009","volume":"240","author":"F Esen","year":"2021","unstructured":"Esen F, Deniz G, Aktas EC (2021) PD-1, CTLA-4, LAG-3, and TIGIT: The roles of immune checkpoint receptors on the regulation of human NK cell phenotype and functions. Immunol Lett 240:15\u201323. https:\/\/doi.org\/10.1016\/j.imlet.2021.09.009","journal-title":"Immunol Lett"},{"issue":"11","key":"3284_CR54","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3390\/cancers12113285","volume":"12","author":"L Quatrini","year":"2020","unstructured":"Quatrini L, Mariotti FR, Munari E, Tumino N, Vacca P, Moretta L (2020) The Immune checkpoint PD-1 in natural killer cells: expression function and targeting in tumour immunotherapy. Cancers (Basel) 12(11):3285","journal-title":"Cancers (Basel)"},{"key":"3284_CR55","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","volume":"8","author":"HO Alsaab","year":"2017","unstructured":"Alsaab HO, Sau S, Alzhrani R, Tatiparti K, Bhise K, Kashaw SK, Iyer AK (2017) PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol 8:561. https:\/\/doi.org\/10.3389\/fphar.2017.00561","journal-title":"Front Pharmacol"},{"issue":"4","key":"3284_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12(4):252\u2013264. https:\/\/doi.org\/10.1038\/nrc3239","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3284_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1399-0039.1985.tb00423.x","volume":"25","author":"RP Warren","year":"1985","unstructured":"Warren RP, Lum LG, Storb R (1985) Is the leukocyte group-5a antigen associated with reduced NK cell function? Tissue Antigens 25(2):107\u2013110. https:\/\/doi.org\/10.1111\/j.1399-0039.1985.tb00423.x","journal-title":"Tissue Antigens"},{"issue":"5","key":"3284_CR58","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4049\/jimmunol.1201542","volume":"190","author":"R Tallerico","year":"2013","unstructured":"Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, Palmieri C, Tirinato L, Pangigadde PN, La Rocca R, Mandelboim O, Stassi G, Di Fabrizio E, Parmiani G, Moretta A, Dieli F, Karre K, Carbone E (2013) Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol 190(5):2381\u20132390. https:\/\/doi.org\/10.4049\/jimmunol.1201542","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03284-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03284-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T06:28:39Z","timestamp":1677133719000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03284-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3284"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03284-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures involved in this study were in accordance with the ethical standards of the Institutional Review Board of the Rambam Health Care Campus (Approval #0114\u201317RMB) and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the participants signed the Informed Consent Form.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}